Dr. Georgios V. Georgakis, MD, PhD

Dr. Georgakis practices at Stony Brook Surgical Associates in Stony Brook, New York.

Dr. Georgakis' NPI, 1952508038, was assigned on July 2, 2007. Dr. Georgakis holds New York license 289527.

Dr. Georgakis' primary practice is Stony Brook Surgical Associates, at 3 Edmund D Pellegrino Rd Ambulatory Surgical Center, Stony Brook, NY 11794-9440. The practice phone is (631) 444-9400.

Dr. Georgakis' primary practice is Stony Brook Surgical Associates in Stony Brook, New York. Dr. Georgakis is also affiliated with Stony Brook University Hospital. The medical group on file is Stony Brook Surgical Associates. Dmand AI also links Dr. Georgakis to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Georgakis practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Georgakis' primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Georgakis is licensed in New York.

Dmand AI lists colon removal among the conditions Dr. Georgakis treats.

CMS data shows 72 Medicare services from Dr. Georgakis across 3 procedure codes in 2024, for 70 Medicare patients. Medicare paid $17,738 for them.

CMS counts 70 Medicare patients who saw Dr. Georgakis in 2024. The largest group is 75 to 84, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Georgakis' median patient age at 62, with 47% women.

In 2024, Dr. Georgakis wrote 17 Medicare Part D claims for 12 patients. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $35 in total drug cost.

Dr. Georgakis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 29 papers to Dr. Georgakis, published from 2008 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Cell Line, Tumor, Cell Proliferation and Hodgkin Disease. Dr. Georgakis has published most often in Br J Haematol. Dr. Georgakis' most frequent co-authors are Leonard Jeffrey Medeiros, MD, Minsig Choi, MD and Aaron R. Sasson, MD.

Dmand AI links Dr. Georgakis to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Pancreatic Neoplasms, Pseudomyxoma Peritonei and Adenocarcinoma, Mucinous.

CMS Open Payments shows 83 general payments to Dr. Georgakis from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 40% of the total. Intuitive Surgical, Inc. paid the most, $7,068.

Dr. Georgakis is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.